Monthly Wegovy Costs: What To Expect When Switching
Understanding Monthly Costs When You Switch Mounjaro To Wegovy
When patients decide to switch Mounjaro to Wegovy, monthly cost considerations often play a significant role in their decision-making process. Wegovy follows a structured 16-week dose escalation protocol, with each dose tier carrying different monthly costs. The initial 0.25mg starter dose costs £79.99 monthly, designed to help your body adjust gradually to semaglutide treatment. This transparent pricing structure allows you to plan your budget effectively throughout the escalation period.
Unlike some competitors who bundle hidden fees or unclear pricing structures, EverydayMeds provides upfront monthly costs for every Wegovy dose. Patients who switch Mounjaro to Wegovy often appreciate this pricing clarity, especially when transitioning from variable insurance coverage or different pharmacy pricing models. Our monthly cost structure includes everything needed: the prescription-only medicine, clinical assessment, prescriber review, and next-day cold-chain delivery to ensure medication integrity.
Complete Wegovy Pricing Structure For Monthly Budgeting
The complete monthly cost progression for patients who switch Mounjaro to Wegovy follows this structure: £79.99 for weeks 1-4 (0.25mg), £94.99 for weeks 5-8 (0.5mg), £99.99 for weeks 9-12 (1mg), and £139.99 for weeks 13-16 (1.7mg). Once you reach the maintenance dose of 2.4mg from week 17 onwards, your monthly cost stabilises at £209.99. New customers benefit from code FIRST40 applied at checkout, while returning customers use DOSE25 to maintain competitive pricing throughout their treatment journey.
For patients planning extended treatment when they switch Mounjaro to Wegovy, our bundle options provide convenience without complexity. The Intro Trio bundle (0.25mg, 0.5mg, 1mg) costs £299.99 and covers your first three months of dose escalation. The Ultimate Stability Trio provides three months of 2.4mg maintenance doses for £649.99, ensuring consistent supply without monthly reordering. These bundles are designed for convenience rather than savings, reducing the frequency of orders while maintaining predictable monthly costs.
Clinical Evidence Supporting The Switch Mounjaro To Wegovy Decision
Wegovy demonstrated significant efficacy in the landmark STEP clinical trial programme, with patients achieving an average of approximately clinically studied weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). In STEP 1, participants taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved substantially greater weight loss compared to placebo (approximately 15% vs 2.4%). The STEP 2 trial specifically evaluated patients with type 2 diabetes, showing an average weight loss of approximately 9.6%.
The recent SELECT cardiovascular outcomes trial demonstrated that Wegovy may reduce major cardiovascular events by 20% in adults with established cardiovascular disease (hazard ratio 0.80). For patients who switch Mounjaro to Wegovy, this growing evidence base provides additional clinical context beyond weight management benefits. However, individual results may vary, and your prescriber will evaluate whether Wegovy is clinically appropriate for your specific circumstances during the assessment process.
How Wegovy Works When You Switch Mounjaro To Wegovy
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone your intestines release after eating. This mechanism helps reduce appetite by acting on brain centres that control hunger and satiety signals. When you switch Mounjaro to Wegovy, you're transitioning from tirzepatide (which targets both GIP and GLP-1 receptors) to semaglutide's GLP-1-only mechanism. Wegovy may help you feel fuller after smaller meals and can reduce food cravings between meals, supporting your reduced-calorie diet efforts. The once-weekly injection schedule provides consistent medication levels throughout the week, maintaining appetite regulation effects.
Streamlined Ordering Process For Wegovy Monthly Supply
Starting your Wegovy treatment after deciding to switch Mounjaro to Wegovy involves a straightforward three-step process designed for convenience and clinical safety. Complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within standard 3 working days (or 24 hours with express review), ensuring Wegovy is clinically appropriate for your circumstances. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled packaging to maintain the medication's efficacy during transit. This efficient process minimises treatment gaps when transitioning between medications.
Storage Advantages And Practical Considerations
Wegovy offers practical storage advantages that many patients appreciate when they switch Mounjaro to Wegovy, particularly regarding travel and convenience. The FlexTouch pen can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Store unused pens in your refrigerator between 2-8°C until first use, and each pen contains four doses for your monthly supply. The dose escalation schedule cannot be skipped or accelerated, requiring progression through 0.25mg, 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose. This gradual escalation helps minimise potential side effects while allowing your body to adjust to the medication.
Cost Comparison Factors When You Switch Mounjaro To Wegovy
Patients who switch Mounjaro to Wegovy often cite monthly cost predictability as a key decision factor, especially when comparing long-term treatment expenses. Wegovy's transparent dose-based pricing eliminates uncertainty about monthly medication costs, allowing accurate annual budgeting for weight management treatment. At the maintenance 2.4mg dose, annual Wegovy costs approximately £2,519.88 (£209.99 × 12 months), providing clear financial planning for ongoing treatment.
The decision to switch Mounjaro to Wegovy should ultimately be guided by your prescriber's clinical recommendation rather than cost alone, as both medications target different receptor mechanisms. Mounjaro (tirzepatide) acts on both GIP and GLP-1 receptors, while Wegovy targets GLP-1 receptors specifically. Both medications are available through EverydayMeds, and your prescriber can help determine which option aligns best with your clinical profile and treatment goals during your assessment.
Securing Your Wegovy Supply With Confidence
EverydayMeds maintains consistent Wegovy stock levels across all dose strengths, ensuring supply continuity when you switch Mounjaro to Wegovy without treatment interruptions. Our GPhC-registered pharmacy (#9012878) sources genuine Novo Nordisk Wegovy directly from licensed UK distributors, guaranteeing authentic prescription-only medicine for every order. Use discount code FIRST40 for new customers or DOSE25 for returning patients to access our competitive pricing structure. Start your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to begin your transition with confidence and clinical oversight. Our experienced team supports your weight management journey with reliable medication supply, transparent monthly costs, and professional pharmaceutical care throughout your treatment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
